Martina Scano
Via U. Bassi 51/B
Padova, 35131, Italy
Padova, 35131, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Repairing the defective folding of alpha-sarcoglycan is needed to promote myogenic cell engraftment in 3D artificial muscle models of LGMDR3.
Journal: Skeletal muscle
Published: May 14, 2025
Efficacy of Cystic Fibrosis Transmembrane Regulator Corrector C17 in Beta-Sarcoglycanopathy-Assessment of Patient's Primary Myotubes.
Journal: International journal of molecular sciences
Published: October 23, 2024
The novel use of the CFTR corrector C17 in muscular dystrophy: pharmacological profile and in vivo efficacy.
Journal: Biochemical pharmacology
Published: October 15, 2024
Advanced therapeutic approaches in sarcoglycanopathies.
Journal: Current opinion in pharmacology
Published: March 01, 2024
Modeling Sarcoglycanopathy in Danio rerio.
Journal: International journal of molecular sciences
Published: July 14, 2023
Synthesis and Evaluation of Bithiazole Derivatives As Potential α-Sarcoglycan Correctors.
Journal: ACS medicinal chemistry letters
Published: February 08, 2023
Reciprocal Homer1a and Homer2 Isoform Expression Is a Key Mechanism for Muscle Soleus Atrophy in Spaceflown Mice.
Journal: International journal of molecular sciences
Published: August 25, 2021
CFTR corrector C17 is effective in muscular dystrophy, in vivo proof of concept in LGMDR3.
Journal: Human molecular genetics
Published: July 13, 2021
Combined Use of CFTR Correctors in LGMD2D Myotubes Improves Sarcoglycan Complex Recovery.
Journal: International journal of molecular sciences
Published: February 13, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026